Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
---|
10/04/1991 | CA2039507A1 Use of dermatan sulphate for the prevention and therapy of cerebral aging and of central nervous system functional deficit states |
10/04/1991 | CA2037877A1 6-alpha hydroxy derivatives of mevinic acids |
10/03/1991 | WO1991015495A1 Benzylphosphonic acid tyrosine kinase inhibitors |
10/03/1991 | WO1991014775A1 Gp75 as a tumor vaccine for melanoma |
10/03/1991 | WO1991014772A1 Production of enzymes in seeds and their use |
10/03/1991 | WO1991014704A2 Treatment of polycystic ovarian disease |
10/03/1991 | WO1991014692A1 Cephalosporins, process for their preparation and pharmaceutical compositions containing them |
10/03/1991 | WO1991014688A1 Hetero polycyclic biocidal compounds and their use in medecine |
10/03/1991 | WO1991014686A1 Azacyclic or azabicyclic compounds, their preparation and use |
10/03/1991 | WO1991014673A1 Novel process for producing benzoic acid derivative |
10/03/1991 | WO1991014668A1 Novel cyclopropyl squalene derivatives and their use as inhibitors of cholesterol synthesis |
10/03/1991 | WO1991014455A1 Aqueous suspension preparation for injection, method for producing the same and use thereof for producing pain relief |
10/03/1991 | WO1991014435A1 Treatment of osmotic disturbance with organic osmolytes |
10/03/1991 | WO1991014434A1 Multi-functional pharmaceutical compounds and methods of use |
10/03/1991 | WO1991014433A1 10-deazaaminopterin: a new arthritis remittive drug |
10/03/1991 | WO1991014431A1 Composition and methods for treatment of acne vulgaris and retardation of ageing |
10/03/1991 | WO1991014429A1 Pharmaceutical compositions containing ipriflavone, process for the preparation thereof and relative therapeutic use |
10/03/1991 | WO1991014368A1 Method of controlling renal secondary hyperparathyroidism |
10/03/1991 | WO1991014367A1 Treatment of central nervous system disorders with imidazole angiotensin-ii receptor antagonists |
10/03/1991 | CA2078791A1 Azacyclic or azabicyclic compounds, their preparation and use |
10/03/1991 | CA2039466A1 Cyclophanes, pharmaceutical compositions containing these compounds and processes for preparing them |
10/03/1991 | CA2039458A1 Methods for treating interleukin-1 mediated diseases |
10/03/1991 | CA2039457A1 Ringer's solution |
10/03/1991 | CA2039009A1 Isochromane derivatives |
10/03/1991 | CA2037876A1 Substituted cyanoimino benzopyranes |
10/02/1991 | EP0449764A2 A method of reducing serum uric acid and/or increasing renal uric acid clearance with thromboxane synthetase inhibitor and/or thromboxane receptor antagonist |
10/02/1991 | EP0449731A1 Anti-inflammatory and/or analgesic pharmaceutical composition for perlingual administration |
10/02/1991 | EP0449728A1 4H-pyrrolo (1,2-a)thieno(2,3-f)(1,4)diazepine derivatives, process for their preparation and pharmaceutical compositions containing them |
10/02/1991 | EP0449722A1 New complexes of tiaprofenic acid or its insoluble or partially soluble esters with cyclodextrines or their derivates |
10/02/1991 | EP0449699A2 Pyrazole derivatives as angiotensin II-receptor antagonists, process for their preparation and pharmaceutical compositions containing them |
10/02/1991 | EP0449649A2 Antineoplastic quinones and methods of using same |
10/02/1991 | EP0449562A2 Use of R-Fluoxetine as selective serotonin IC-receptor ligands |
10/02/1991 | EP0449561A2 Use of (R)-norfluoxetine in the preparation of a medicament with affinity to 5HT1c receptors |
10/02/1991 | EP0449523A1 Mercapto- or acylthio-trifluoromethyl amide derivatives and their use |
10/02/1991 | EP0449515A2 Novel cephalosporin intermediates and process for preparing the intermediates and their end products |
10/02/1991 | EP0449463A2 Method and composition for iontophoresis |
10/02/1991 | EP0449427A2 Use of an antihistamine in the treatment of alcohol intoxication |
10/02/1991 | EP0449426A1 A pharmaceutical composition |
10/02/1991 | EP0449405A2 Use of bisphosphonic acids for the treatment of calcium metabolism disorders |
10/02/1991 | EP0449376A2 Production of enzymes in seeds and their use |
10/02/1991 | EP0449346A2 4-Piperidinyl-ergoline derivatives |
10/02/1991 | EP0449301A1 Propanobicyclic amine derivatives for CNS disorders |
10/02/1991 | EP0449294A1 Hydroxymethyl-indolizidines and quinolizidines |
10/02/1991 | EP0449247A2 Pharmaceutical composition containing Galanthamine for treating alcoholism |
10/02/1991 | EP0449223A1 3,5-di-tertiary-butyl-4-hydroxyphenyl thiazolyl, oxa-zolyl, and imidazolyl methanones and related compounds as antiinflammatory agents |
10/02/1991 | EP0449216A1 3,5-di-tertiarybutyl-4-hydroxyphenylmethylene derivatives of 2-substituted thiazolidinones, oxazolidinones, and imidazolidinones as antiinflammatory agents |
10/02/1991 | EP0449211A1 3,5-ditertiarybutyl-4-hydroxyphenyl, 1,3,4-thiadiazoles and oxadiazoles linked by carbon, oxygen, and sulfur residues |
10/02/1991 | EP0449195A2 Aminobenzene compounds, their production and use |
10/02/1991 | EP0449187A2 Piperidin ether derivatives as psychotropic drugs or plant fungicides |
10/02/1991 | EP0449186A2 N-aralkyl piperidine derivatives as psychotropic drugs |
10/02/1991 | EP0449175A2 Selective adenosine receptor agents |
10/02/1991 | EP0449167A1 Process for preparing piroxicam/cyclodextrin complexes, the products obtained and their pharmaceutical compositions |
10/02/1991 | EP0449099A2 Retinoide derivatives, their preparation and their use for medicaments |
10/02/1991 | EP0449079A2 Hydantoin derivative |
10/02/1991 | EP0449026A2 Desoxynojirimycin derivatives, process for their preparation and their use in drugs |
10/02/1991 | EP0449009A2 Use of gallopamil for the preparation of medicaments for the treatment of acute renal failure |
10/02/1991 | EP0448961A2 Nitroglycerine pumpspray |
10/02/1991 | EP0448940A2 Process for the preparation of mannosyl teicoplanin derivatives and mannosyl teicoplanin aglycone |
10/02/1991 | EP0448934A2 Di- and tetra-fluoro analogs of squalene as inhibitors of squalene epoxidase |
10/02/1991 | EP0448895A1 Use of a non-alcoholic delivery system for active ingredients which are ingested orally |
10/02/1991 | EP0448856A1 Ophthalmic preparations comprising timolol maleate |
10/02/1991 | EP0448850A1 2-Alkyl-3-benzoylbenzofurans useful for treating cardiac arrhythmia |
10/02/1991 | EP0448765A1 Use of guanidine derivatives for the manufacture of a medicament with NPY-antagonistic activity |
10/02/1991 | EP0448652A1 Inhibitors of agonist-specific desensitization |
10/02/1991 | EP0448637A1 Heparin fragments as inhibitors of smooth muscle cell profileration |
10/02/1991 | EP0448636A1 Dermal uses of non-irritating retinoids |
10/02/1991 | EP0448583A1 Organometallic compounds, process for producing them and pharmaceutical compositions containing them |
10/02/1991 | EP0448552A1 IMPROVED PROCESS FOR $i(TRANS)-6- 2-(SUBSTITUTED-PYRROL-1-YL)ALKYL]PYRAN-2-ONE INHIBITORS OF CHOLESTEROL SYNTHESIS |
10/02/1991 | EP0448550A1 New derivatives of deoxy-2'-uridine substituted in the 5, 3' or 5' position by acylated alpha-amino groups, process for obtaining them and drugs containing them. |
10/02/1991 | EP0309533B1 Butyl hydroxyanisoles for the treatment of retroviral diseases |
10/02/1991 | EP0227813B1 11-beta-nitrate-substituted estranes |
10/02/1991 | DE4010355A1 Bicyclo(3.3.0)octan-derivate, verfahren zu ihrer herstellung und ihre pharmazeutische verwendung Bicyclo (3.3.0) octane derivatives, process for their production and their pharmaceutical use |
10/02/1991 | DE4010228A1 Prepn. of antiviral, esp. anti-AIDS agent - by mixing halo-contg. higher alkyl-glycerol-phospho-choline analogues with suitable carrier |
10/02/1991 | DE4010097A1 Ungesaettigte n-benzoxodiazolopyranyllactame, ihre herstellung und verwendung Unsaturated n-benzoxodiazolopyranyllactame, their preparation and use |
10/02/1991 | CN1054984A Process for preparation of 7-amino-3-methoxymethyl-ceph-3-em-4-carboxylic acid |
10/02/1991 | CN1054982A Substituted purine, process for preparing same and use as antiviral |
10/02/1991 | CN1054981A Therapeutic nucleosides |
10/02/1991 | CN1054979A Oleandomycin oximes, preparation and use thereof |
10/02/1991 | CN1054978A Novel ascorbic acid derivatives |
10/02/1991 | CN1054900A Compositions and methods for treating infections caused by organisms sensitive to beta-lactam antibiotics |
10/02/1991 | CN1014148B Process for preparation of 2,3-dihydrobenzofuran-5-sulfonylamine derivs. |
10/02/1991 | CA2013661A1 Benzyl-cyclanone derivatives, process for their preparation and cosmetic and pharmaceutical compositions containing the same |
10/01/1991 | WO1991015209A1 Substituted pyrimidines, pyrimidinones and pyridopyrimidines |
10/01/1991 | US5053548 Biphenyl derivative composition for nerve cell degeneration repairing or protective agent and process for preparing a phenyl derivative contained in the composition |
10/01/1991 | US5053547 Benzonorbornene derivatives, processes for their preparation and medicinal and cosmetic compositions containing them |
10/01/1991 | US5053526 Pharmaceuticals containing prostaglandin I2 |
10/01/1991 | US5053521 3-amino butyric acid uptake inhibitors, antiepileptic agents |
10/01/1991 | US5053519 Hypotensive agents; diuretics; vasodilation |
10/01/1991 | US5053514 Side effect reduction; carbostyril derivatives |
10/01/1991 | US5053511 Analgesics; anticonvulsants; treatment for alzheimers disease |
10/01/1991 | US5053510 Process for the preparation of polycyclic compounds |
10/01/1991 | US5053509 Benzo[1,8]naphthyridine derivatives, their preparation and compositions containing them |
10/01/1991 | US5053499 2',3'-dideoxy purine nucleoside |
10/01/1991 | US5053498 Therapeutic and prophylactic agents for peptic ulcer |
10/01/1991 | US5053433 Cosmetic composition with anticellulitic and slimming action, in which the active principle is a 1-hydroxyalkylxanthine |
10/01/1991 | US5053430 Use of 2,7-diamino-1,2,3,4-tetrahydronaphthalenes as medicaments, new 2,7-diamino-1,2,3,4-tetrahydronaphthalenes and processes for their preparation |
10/01/1991 | US5053429 Treating inflammatory pain with methionine |
10/01/1991 | US5053427 Guanidino-substituted benzopyrans and their use as pharmaceuticals |
10/01/1991 | US5053424 2-(n-acyl)amino-6,7-dimethoxy tetralines, and pharmaceutical compositions having antihypertensive activity containing same |
10/01/1991 | US5053422 Learning-memory enhancers; nootropic agents |